Atlas Trials

A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes

Clinical trial NCT04378920 · COMPLETED

Trial details

NCT number
NCT04378920
Sponsor
Institut de cancérologie Strasbourg Europe
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
COVID19, Sepsis or Other CausesAcute Respiratory Distress Syndrome
Start date
2020-04-14
Primary completion
2021-08-24
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.